Multiple diagnostic X-rays for spine deformities and risk of breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 3, 2008, Pages 605-613

  Ronckers, Cécile M ^a   Doody, Michele M ^a   Lonstein, John E ^b   Stovall, Marilyn ^c   Land, Charles E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TWIN CITIES SPINE CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE; SPINE MALFORMATION; X RAY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA DAMAGE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; QUESTIONNAIRES; RADIATION DOSAGE; RADIOGRAPHY; RETROSPECTIVE STUDIES; RISK; SCOLIOSIS;

EID: 41549133437     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2628     Document Type: Article

References (53)

1. Preston DL, Mattson AM, Holmberg E, Shore R, Hildreth N, Boice JD, Jr. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 2002;158:220-35. Erratum in: Radiat Res 2002;158:666.
2. Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer. A review of current evidence. Breast Cancer Res 2005;7:21-32.
3. Morin Doody M, Lonstein JE, Stovall M, Hacker DG, Luckyanov N, Land CE. Breast cancer mortality after diagnostic radiography. Spine 2000;25:2052-63.
4. Paterson A, Frush DP, Donnelly LF. Helical CT of the body: are settings adjusted for pediatric patients? AJR Am J Roentgenol 2001;176:297-301.
5. Holmberg E, Holm LE, Lundell M, Mattsson A, Wallgren A, Karlsson P. Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy. Br J Cancer 2001;85:362-6.
6. van Leeuwen FE, Klokman WJ, Stovall M, et al. The roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003;95:971-80.
7. Land CE, Hayakawa N, Machado SG, et al. A case-control interview study among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control 1994;5:167-76.
8. Shore RE, Woodard ED, Hempelmann LH, Pasternack BS. Synergism between radiation and other risk factors for breast cancer. Prev Med 1980;9:815-22.
9. Hill DA, Preston-Martin S, Ross RK, Bernstein L. Medical radiation, family history of breast cancer, and benign breast disease in relation to breast cancer risk in young women. Cancer Causes Control 2002;13:711-8.
10. Boice JD, Jr., Stone BJ. Interaction between radiation and other breast cancer factors. In: Kawabayashi S, editor. Late biological effects of ionizing radiation. Vol 1, 231-49. Vienna (Austria): International Atomic Energy Agency; 1978.
11. Hill DA, Gilbert E, Dores GM, et al. Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood 2005;106:3358-65.
12. Moolgavkar SH, Day NE, Stevens RG. Two-stage model for carcinogenesis: epidemiology of breast cancer in females. J Natl Cancer Inst 1980;65:559-69.
13. Land CE, Tokunaga M, Tokuoka S, Nakamura N. Early-onset breast cancer in A-bomb survivors [letter]. Lancet 1993;342:237.
14. Korenman SG. Oestrogen window hypothesis of the aetiology of breast cancer. Lancet 1980;1:700-1.
15. Russo J, Russo IH. Toward a unified concept of mammary carcinogenesis. Prog Clin Biol Res 1997;396:1-16.
16. Hoffman DA, Lonstein JE, Morin MM, Visscher W, Harris BS III, Boice JD, Jr. Breast cancer in women with scoliosis exposed to multiple diagnostic x rays. J Natl Cancer Inst 1989;81:1307-12.
17. Marshall WA, Tanner JM. Variations in pattern of pubertal change in girls. Arch Dis Child 1969;44:291-303.
18. Speroff L, Glass RH, Kase NG, editors. Clinical gynaecologic endocrinology and infertility. 5th ed. Baltimore (MD): Williams & Wilkins; 1994.
19. WHO. Manual of the international statistical classification of diseases, Injuries and causes of death (ICD-9). Geneva (Switzerland): WHO; 1975.
20. Preston DL, Lubin JH, Pierce DA. Epicure User's Guide. Seattle (WA): HiroSoft International; 1991.
21. Pearson ES, Hartley HO, editors. Biometrika tables for statisticians. 3rd ed. London (UK): Biometrika Trust; 1976.
22. Breslow NE, Day NE. Statistical methods in cancer research - vol 2: the design and analysis of cohort studies. Lyon (France): IARC; 1987.
23. Land CE, Tokunaga M, Koyama K, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res 2003;160:707-17.
24. Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-94.
25. van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000;18:487-97.
26. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 2003;21:4386-94.
27. Mattson A, Rudén B-I, Hall P, Wilking N, Rutqvist LE. Radiation-associated breast cancer: long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst 1993;85:1679-85.
28. Boice JD, Preston D, Davis FG, Monson RR. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991;125:215-22.
29. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivor study. Radiat Res 1996;145:694-707.
30. Shore RE, Hildreth N, Woodard E, Dvoretsky P, Hempelmann L, Pasternack B. Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 1986;77:689-96.
31. Hildreth NG, Shore RE, Dvoretsky PM. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989;321:1281-4.
32. Lundell M, Mattsson A, Karllson P, Holmberg E, Gustafsson A, Holm L-E. Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat Res 1999;151:626-32.
33. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and effects of ionizing radiation. New York: United Nations; 2003.
34. Ries LAG, Harkins D, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2003. Bethesda (MD): National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2003/based on November 2005 SEER data submission, posted to the SEER Web site; 2006.
35. Millikan RC, PLayer JS, deCotret AR, Tse C-K, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:2326-34.
36. Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer. A report from the Childhood Cancer Survivor Study. Ann Intern Med 2004;141:590-7.
37. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
38. Hopper JL. Genetic epidemiology of female breast cancer. Semin Cancer Biol 2001;11:367-74.
39. Petersen GM. Familial aggregation: sorting susceptibility from shared environment [editorial]. J Natl Cancer Inst 2000;92:114-5.
40. Miller NH, Justice CM, Marosy B, et al. Identification of candidate regions for familial idiopathic scoliosis. Spine 2005;30:1181-7.
41. Inoue M, Minami S, Nakata Y, et al. Associations between estrogen receptor gene polymorphisms and curve severity of idiopathic scoliosis. Spine 2002;27:2357-62.
42. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiation Research 2007;168:1-64.
43. Sigurdson AJ, Doody MM, Rao RS, et al. Cancer incidence in the U.S. Radiologic Technologists Health Study, 1984-1998. Cancer 2003;97:3080-9.
44. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900.
45. Floderus B, Barlow L, Mack TM. Recall bias in subjective reports of familial cancer. Epidemiology 1990;1:318-21.
46. Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 1994;3:321-7.
47. Murff HJ, Spigel DR, Sungal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004;292:1480-9.
48. Ziogras A, Anton-Culver. Validation of family history data in cancer family registries. Am J Prev Med 2003;24:190-8.
49. Eerola H, Blomqvist C, Pukkula E, Pyrhönen S, Nevanlinna H. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 2000;36:1143-8.
50. Berrington de Gonzalez A, Ekbom A, Glass AG, et al. Comparison of documented and recalled histories of exposure to diagnostic X-rays in case-control studies of thyroid cancer. Am J Epidemiol 2003;157:652-63.
51. Pogoda JM, Preston-Martin S. Radiation exposure from diagnostic imaging: agreement between self-report and medical records. Health Phys 2002;83:907-17.
52. Pogoda JM, Preston-Martin S. The potential impact of incomplete radiography histories in epidemiologic studies that rely on prepaid health plan records. Health Phys 2002;83:567-70.
53. Butler PF, Thomas AW, Thompson WE, Wollerton MA, Rachlin JA. Simple methods to reduce patient exposure during scoliosis radiography. Radiol Technol 1986;57:411-7.